Corrigendum to "HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE)" [Int. Immunopharmacol. 78 (2020) 105943
| Errataetall: |
ErratumFor: Int Immunopharmacol. 2020 Jan;78:105943. - PMID 31830622 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
|---|---|
| Enthalten in: |
International immunopharmacology - 88(2020) vom: 15. Nov., Seite 106742 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Karampoor, Sajad [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 10.11.2020 published: Print-Electronic ErratumFor: Int Immunopharmacol. 2020 Jan;78:105943. - PMID 31830622 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.intimp.2020.106742 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313802610 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313802610 | ||
| 003 | DE-627 | ||
| 005 | 20231225151343.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.intimp.2020.106742 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1045.xml |
| 035 | |a (DE-627)NLM313802610 | ||
| 035 | |a (NLM)32805692 | ||
| 035 | |a (PII)S1567-5769(20)32096-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Karampoor, Sajad |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Corrigendum to "HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE)" [Int. Immunopharmacol. 78 (2020) 105943 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 10.11.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumFor: Int Immunopharmacol. 2020 Jan;78:105943. - PMID 31830622 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 650 | 4 | |a Published Erratum | |
| 700 | 1 | |a Zahednasab, Hamid |e verfasserin |4 aut | |
| 700 | 1 | |a Bokharaei-Salim, Farah |e verfasserin |4 aut | |
| 700 | 1 | |a Mirzaei, Rasoul |e verfasserin |4 aut | |
| 700 | 1 | |a Mojallal-Tabatabaei, Zahra |e verfasserin |4 aut | |
| 700 | 1 | |a Esghaeia, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a Keyvani, Hossein |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 88(2020) vom: 15. Nov., Seite 106742 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2020 |g day:15 |g month:11 |g pages:106742 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2020.106742 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 88 |j 2020 |b 15 |c 11 |h 106742 | ||